Paediatric Haematology and Oncology

Doç. Dr. Koray Yalçın

Doctor and researcher Acıbadem Altunizade HastanesiAcıbadem Atakent Hastanesi İstanbul
Graft vs Host DiseaseThalassemiaMucopolysaccharidosis IVLymphoproliferative DisordersSevere Combined ImmunodeficiencyCOVID-19Cytomegalovirus Infectionsbeta-ThalassemiaLymphoma, Non-HodgkinLeukemia, Myeloid, AcuteSarcoma, Synovial
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Graft vs Host Disease 12 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Thalassemia 3 publications
  • Mucopolysaccharidosis IV 2 publications
  • Lymphoproliferative Disorders 2 publications
  • Severe Combined Immunodeficiency 2 publications
  • COVID-19 2 publications
  • Cytomegalovirus Infections 2 publications
  • beta-Thalassemia 2 publications
  • Lymphoma, Non-Hodgkin 2 publications
  • Leukemia, Myeloid, Acute 2 publications
  • Sarcoma, Synovial 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.

  • Çocuklarda Demir Eksikliği ve Anemi
  • Akdeniz Anemisi (Talasemi)
  • Lösemi
  • Myelodisplastik Sendrom (MDS)
  • Lenfoma (Hodgkin Lenfoma ve Hodgkin Dışı Lenfoma)
  • Kemik İliği Nakli
  • Hücresel Tedaviler
  • Lenf Kanseri (Lenfoma)

CV

Education and experience

From source

Experience

  • 2026Acıbadem Sağlık Grubuacibadem.com.tr
  • 2019 - 2024Bahçeşehir Üniversitesi Medikal Park Göztepe Hastanesi Pediatrik Hematoloji- Onkoloji ve Kemik İliği Nakil Ünitesi Sorumlu Hekimiacibadem.com.tr
  • 2019Acıbadem Labcell Hücresel Tedaviler Merkezi Araştırmacıacibadem.com.tr

Education

  • 2021Acıbadem Üniversitesi Sağlık Bilimleri Enstitüsü Medikal Biyoteknoloji Doktora, Digeracibadem.com.tr
  • 2018Goethe Üniversitesi-Uniklinik Frankfurt Johanna Quandt Pediatrik Kök Hücre Nakli ve Hücresel Tedaviler Merkezinde Gözlemci Araştırmacı, Digeracibadem.com.tr
  • 2017Akdeniz Üniversitesi Tıp Fakültesi, Çocuk Hematolojisi ve Onkolojisi, Üst Uzmanlıkacibadem.com.tr
  • 2014İstanbul Taksim Eğitim ve Araştırma Hastanesi?nde Pediatri Uzmanlığı, Digeracibadem.com.tr
  • 2013Okmeydanı Eğitim ve Araştırma Hastanesi, Çocuk Sağlığı ve Hastalıkları, Uzmanlıkacibadem.com.tr
  • 2008İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, Üniversiteacibadem.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyPaediatric Haematology and Oncologyacibadem.com.trFrom source
  • Department name at the sourceÇocuk Hematolojisiacibadem.com.trFrom source
  • InstitutionAcıbadem Altunizade Hastanesi, Acıbadem Atakent Hastanesiacibadem.com.trFrom source
  • Area of workGraft vs Host DiseaseExtracted from 12 publications · Model version —From source
  • Publications74 publicationsOpenAlexFrom source
  • Last synchronised4 November 2026 20:59https://www.acibadem.com.tr/doktor/koray-yalcin/acibadem.com.tr

Scientific work

Publications on Graft vs Host Disease

74 publications

  1. Improving outcomes in patients' refractory to standard therapies: Dual-Mechanism to Mitigate Antigen Escape for Bridge-to-Transplant Immunotherapy

    AHFE international, 2026

    DOI 10.54941/ahfe1007478 Source: OpenAlex

  2. Allogeneic Hematopoietic Cell Transplantation for Morquio A Syndrome: An International Retrospective Study

    Transplantation and Cellular Therapy, 2026

    DOI 10.1016/j.jtct.2026.01.029 PMID 41616943 2 citations (Europe PMC) Source: OpenAlex

  3. Dornase Alfa as a Potential Treatment Option for SARS-CoV-2: In Vitro Insights

    Fabad Journal of Pharmaceutical Sciences, 2026

    DOI 10.55262/fabadeczacilik.1777903 Source: OpenAlex

  4. Real-world outcomes of children with first relapsed acute lymphoblastic leukemia treated according to the ALL-IC REL 2016 guideline in Türkiye

    Annals of Hematology, 2026

    DOI 10.1007/s00277-026-07281-w Open-access full textSource: OpenAlex

  5. The Pretransplant EASIX Score Predicts Transplant‐Related Mortality in Children Undergoing Hematopoietic Stem Cell Transplantation for Non‐Malignant Disorders

    Clinical Transplantation, 2026

    DOI 10.1111/ctr.70487 PMID 41729158 Source: OpenAlex

  6. Frequency, Characteristics, Management, and Outcomes of Posttransplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Multicentre Retrospective Study of the Turkish Pediatric BMT Study Group

    Turkish Journal of Hematology, 2026

    DOI 10.4274/tjh.galenos.2026.55376 PMID 41778738 Open-access full textSource: OpenAlex

  7. Genetic heterogeneity in childhood leukemia/lymphoma: a Turkish cohort with strong predisposition

    Frontiers in Genetics, 2025

    DOI 10.3389/fgene.2025.1624306 PMID 40995433 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  8. Hematopoietic stem cell transplantation in pediatric patients with type VI mucopolysaccharidosis

    Korean Journal of Pediatrics, 2025

    DOI 10.3345/cep.2024.02033 PMID 40083103 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  9. Bridging the Gap in Pediatric Relapsed Acute Lymphoblastic Leukemia Treatment: Insights and Outcomes From the ALL‐IC REL 2016 Guidelines

    Pediatric Blood & Cancer, 2025

    DOI 10.1002/pbc.32063 PMID 41041698 1 citation (Europe PMC) Source: OpenAlex

  10. Effect of genetic mutations on outcomes of stem cell transplantation in children with hemophagocytic lymphohistiocytosis

    Bone Marrow Transplantation, 2025

    DOI 10.1038/s41409-025-02592-4 PMID 40263637 3 citations (Europe PMC) Open-access full textSource: OpenAlex

View all 74 publications